학술논문

Early 3+3 Trial Dose-Escalation Phase I Clinical Trial Design and Suitability for Immune Checkpoint Inhibitors
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; JAN 15 2021, 27 2, p485-p491, 7p.
Subject
Language
English
ISSN
15573265